CITIGROUP INC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 60 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$454,175
-15.7%
582,275
+0.0%
0.00%
Q2 2023$538,531
+29752.1%
582,196
+35078.0%
0.00%
Q1 2023$1,804
-37.0%
1,655
-15.6%
0.00%
Q4 2022$2,865
-59.1%
1,962
-70.5%
0.00%
Q3 2022$7,000
-86.8%
6,649
-78.8%
0.00%
Q2 2022$53,000
+20.5%
31,431
+45.9%
0.00%
Q1 2022$44,000
-61.1%
21,537
-28.3%
0.00%
Q4 2021$113,000
-47.9%
30,049
-28.4%
0.00%
Q3 2021$217,000
+1.9%
41,991
-15.9%
0.00%
Q2 2021$213,000
-53.4%
49,923
-42.0%
0.00%
Q1 2021$457,000
+75.1%
86,001
+77.3%
0.00%
Q4 2020$261,000
+3162.5%
48,503
+4467.1%
0.00%
Q3 2020$8,000
-20.0%
1,062
+6.9%
0.00%
Q2 2020$10,000
+66.7%
993
-54.5%
0.00%
Q1 2020$6,0002,182
+10810.0%
0.00%
Q4 2019$0
-100.0%
20
-99.1%
0.00%
Q3 2019$3,000
-66.7%
2,184
+1.6%
0.00%
Q2 2019$9,000
+80.0%
2,149
+89.3%
0.00%
Q1 2019$5,000
-94.0%
1,135
-81.6%
0.00%
Q3 2018$84,000
+15.1%
6,1750.0%0.00%
Q2 2018$73,000
+2333.3%
6,175
+2089.7%
0.00%
Q1 2018$3,000
-75.0%
282
-84.7%
0.00%
Q4 2017$12,0001,846
+184500.0%
0.00%
Q1 2016$0
-100.0%
1
-100.0%
0.00%
Q3 2015$62,0005,2110.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$1,501,2502.44%
NEA Management Company, LLC 17,079,779$18,616,9581.29%
Endurant Capital Management LP 1,660,835$1,810,3100.93%
Matrix Capital Management Company, LP 38,974,185$42,481,8620.58%
Long Focus Capital Management, LLC 5,435,439$5,924,6290.34%
PFM Health Sciences, LP 5,992,571$6,531,9020.29%
Key Client Fiduciary Advisors, LLC 321,155$350,0590.22%
DAFNA Capital Management LLC 351,064$382,6600.12%
Rock Springs Capital Management LP 2,787,845$3,038,7510.07%
Baker Brothers Advisors 9,830,877$10,715,6560.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders